ArticleAdvances in radiation oncology2026

Heterogeneous Radioimmunotherapy for Bulky Tumors: A Phase 1 Trial for Advanced Non-Small Cell Lung Cancer.

Ren Luo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.